KRISTINA KOHUTH: Open Payments
NPI 1104392588 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,648 in 279 payments from 23 companies in 2025. Trend: 2023 $5,037 · 2024 $5,017 · 2025 $5,648
Food & beverage: $5,538Education: $109
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 45 | $696 |
| Teva Pharmaceuticals USA, Inc. | 26 | $681 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $650 |
| Otsuka America Pharmaceutical, Inc. | 34 | $643 |
| Alkermes, Inc. | 21 | $513 |
| Neurocrine BioSciences, Inc. | 19 | $460 |
| Axsome Therapeutics, Inc. | 23 | $409 |
| Tris Pharma Inc | 12 | $273 |
| Janssen Pharmaceuticals, Inc | 14 | $272 |
| Vanda Pharmaceuticals Inc. | 18 | $204 |
Products named: CAPLYTA, VRAYLAR, INGREZZA, Auvelity, ARISTADA, REXULTI, AUSTEDO XR, Dyanavel XR.
Industry payments across NC — which companies pay providers there.
